Table 2.
Clinical findings (HPO identifier) | Frequency | % |
---|---|---|
Ancestry | 2 Asian, 4 European | – |
Sex | 3 male, 3 female | – |
De novo inheritance (HP:0025352) | 6/6 | 100.0 |
Intellectual disability (HP:0001249) | 5/6 | 83.3 |
Neurodevelopmental delay (HP:0012758) | 5/6 | 83.3 |
Abnormality of the musculoskeletal system (HP:0033127) | 4/6 | 66.7 |
Seizure (HP:0001250) | 3/6 | 50.0 |
Abnormal facial shape (HP:0001999) | 3/6 | 50.0 |
Brain imaging abnormality (HP:0410263) | 3/6 | 50.0 |
Abnormality of the genitourinary system (HP:0000119) | 3/6 | 50.0 |
Microcephaly (HP:0000252) | 2/6 | 33.3 |
Hearing impairment (HP:0000365) | 2/6 | 33.3 |
Failure to thrive (HP:0001508) | 2/6 | 33.3 |
Abnormal heart morphology (HP:0001627) | 2/6 | 33.3 |
Autistic behavior (HP:0000729) | 2/6 | 33.3 |
Abnormality of the endocrine system (HP:0000818) | 1/6 | 16.7 |
Abbreviation: HPO, human phenotype ontology.